Increased pressure alters plasma membrane dynamics and renders acute myeloid leukemia cells resistant to daunorubicin

Although environmental factors such as cytokines and stroma are recognized to influence the growth and chemosensitivity of acute myeloid leukemia (AML) cells, little is known about the effect of physical forces such as pressure. The pressure in the marrow of AML patients can be 10–20 fold higher compared to patients with solid tumors or non-malignant conditions,1 possibly due to increased cellularity and fibrosis. Therefore, we sought to establish whether the pressure in the marrow is another environmental factor that can influence chemosensitivity. Using AML cell lines and primary patient samples, we show that high pressure promotes a transition to a gel-like plasma membrane that reduces the intracellular accumulation of daunorubicin in AML cells. Therefore, biomechanical stimulus such as pressure is another environmental factor that can influence chemosensitivity. We designed and manufactured pressure chambers to deliver different levels of physiological pressure to AML cells while maintaining continuous gas exchange (Online Supplementary Figure S1). Two AML cell lines, HL60 and TEX, were cultured at pressures up to 310 mmHg above atmospheric pressure (atm). A pressure of 310 mmHg above atm corresponds to less than 0.5% of the maximum pressure acting on the head of the femur of an upright 160 lb person, and therefore, would be physiologically relevant as erosion of the trabeculae from leukemic infiltration increases sensitivity to external forces.1,2 We found that the growth and viability of these cell lines did not change at high pressure (Figure 1A). Next, we explored the impact of increased pressure on the sensitivity of these cells to three anthracyclines used in the treatment of AML: daunorubicin, idarubicin, and mitoxantrone.3,4 HL60 and TEX cells grown at increased static pressure were more resistant to daunorubicin, (Figure 1B), but not idarubicin (Figure 1C) or mitoxantrone (Figure 1D and Online Supplementary Figure S2). Furthermore, the effects of increased pressure on chemosensitivity were reversible. Figure 1. Acute myeloid leukemia (AML) cells at increased pressure display chemoresistance to danorubicin. (A). Cell viability measured by trypan blue exclusion assay of HL60 and TEX leukemia cells cultured over 4 days at 37°C at atmospheric pressure (atm) ... We also tested the impact of increased static pressure on samples from 5 patients with acute leukemia (4=AML, 1=T-ALL) that were sensitive to daunorubicin (patients’ characteristics are shown in Online Supplementary Table S1). Similar to the cell lines, increased pressure did not alter the growth and viability of the primary cells, but 3 of 5 samples (3 of 4 AML samples) had reduced sensitivity to daunorubicin at high pressure (Figure 1E and Online Supplementary Figure S3). To investigate the biological effects of increased pressure that may influence chemosensitivity, we measured the intracellular accumulation of daunorubicin. Compared to cells at atm, cells cultured at increased pressure accumulated less daunorubicin (Figure 2A and Online Supplementary Figure S4). In contrast, we observed no difference in the accumulation of [3H] mitoxantrone in TEX cells treated at increased pressure (Figure 2B). Figure 2. AML cells have reduced daunorubicin accumulation at increased pressure. (A). HL60 and TEX cells were cultured at 37°C at atm and 310 mmHg above atm for 3 days and then treated with 80, 160 and 320 nM of [3H] daunorubicin for 3 hours at the same ... No prior studies have investigated the impact of static pressure on plasma membrane dynamics in cancer cells. However, studies on red blood cells,5,6 bacterial membranes7 and synthetic lipid vesicles8,9 demonstrate that increased pressure alters membrane dynamics and influences drug and particle uptake. In these systems, the acyl chains of the phospholipids in the membrane straighten under increased pressure causing the membrane to become thicker and transition from a fluid liquid-crystalline state to a more solid gel-like state. The thicker gel-like membrane can reduce the permeability of the membrane to small molecules and can also impair the activity of membrane-associated drug uptake channels. Notably, these changes in membrane dynamics are rapidly reversible upon returning to normal pressure. To determine if plasma membrane dynamics are altered in AML cells at increased pressure, HL60, TEX, and primary patient AML cells were cultured at high pressure and stained with the lipophilic probe, laurdan (6-dodecanoyl-2-dimethylaminonaphthalene) (see Online Supplementary Appendix for description of method). The fluorescence spectrum of laurdan is sensitive to the physical state of membrane phospholipids, and has been used to evaluate plasma membrane dynamics in red blood cells exposed to increased pressure6 and in K562 leukemia cells exposed to increased temperatures.10 Using two- photon microscopy at 37°C, atm, and within 10 min of removing from the pressure chamber, we calculated the generalized polarization (GP) factor of laurdan and observed an increase in the gel-like state of the membrane in both HL60 and TEX cells cultured at high pressure (Figure 2C). Moreover, primary AML cells from patients 1, 2, and 3 that demonstrated a change in chemosensitivity to daunorubicin at higher pressure also showed an increase in the gel-like state in their membrane at increased pressure. In contrast, primary cells from patients 4 (T-ALL) and 5 (AML) that did not display a change in chemosensitivity at increased pressure also showed no change in membrane dynamics at increased pressure (Figure 2D and Online Supplementary Figure S5). Thus, in a subset of AML cells, increased pressure promotes a transition to a gel-like membrane that can reduce the intracellular accumulation of select anthracyclines. Cholesterol is an important regulator of plasma membrane structure and consistency, and the amount of cholesterol in the membrane can vary over 10-fold between cells. Prior studies have evaluated the impact of cholesterol content on membrane dynamics after exposure to biomechanical forces. For example, addition of cholesterol to endothelial cells decreased membrane fluidity and dampened the impact of sheer stress on the plasma membrane.11 Similarly, using synthetic lipid vesicles, as the amount of cholesterol in the vesicle increased, the membrane became more gel-like and little further change was observed upon exposure to increased pressure.12 Conversely, membranes with the least amount of cholesterol are the most liquid and show the greatest change in their membrane dynamics upon exposure to increased pressure. However, it is unknown whether cells alter their membrane composition in response to changes in biomechanical pressure. It is worthy of note that the tested anthracyclines vary in their hydrophobicity. Of the three agents, daunorubicin has the highest logP (logarithm of partition coefficient) value of 1.83 indicating that it is the most hydrophobic, while idarubicin and mitoxantrone have lower logP values of 0.2 and -3.1, respectively. Changes in membrane dynamics would, therefore, preferentially affect the more hydrophobic daunorubicin compared to the other agents. Our study is not without limitations. First, membrane phase transitions are generally rapidly reversible and the imaging was done at atm. Although we imaged the cells within 10 min of removal from the pressure chamber, some of the changes in membrane dynamics may have reversed before imaging could be completed. Second, the increased pressure could have decreased daunorubicin solubility and thus resulted in decreased sensitivity to the drug, although this is very unlikely as we did not detect precipitation of daunorubicin. In summary, our study shows that increased static pressure renders AML cells resistant to daunorubicin by reducing intracellular drug levels, but does not affect sensitivity to idarubicin and mitoxantrone. Thus, these results highlight biomechanical stimuli such as pressure as another environmental factor that can influence chemosensitivity. Moreover, it suggests that some AML patients might benefit from chemotherapeutic regimens that contain anthracyclines such as idarubicin or mitoxantrone rather than daunorubicin.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.